Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthofix Medical (OFIX) EPS (Basic) (2016 - 2026)

Orthofix Medical has reported EPS (Basic) over the past 17 years, most recently at -$0.52 for Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 61.48% year-over-year to -$0.52, compared with a TTM value of -$1.5 through Mar 2026, up 59.35%, and an annual FY2025 reading of -$2.33, up 29.39% over the prior year.
  • EPS (Basic) came in at -$0.52 for Q1 2026, down from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.12 in Q2 2022 to a low of -$1.71 in Q1 2023.
  • Median EPS (Basic) over the past 5 years was -$0.59 (2023), compared with a mean of -$0.66.
  • The sharpest move saw EPS (Basic) plummeted 991.67% in 2023, then soared 93.33% in 2025.
  • Over 5 years, EPS (Basic) stood at -$0.35 in 2022, then tumbled by 68.57% to -$0.59 in 2023, then fell by 27.12% to -$0.75 in 2024, then soared by 93.33% to -$0.05 in 2025, then plummeted by 940.0% to -$0.52 in 2026.
  • Per Business Quant, the three most recent readings for OFIX's EPS (Basic) are -$0.52 (Q1 2026), -$0.05 (Q4 2025), and -$0.57 (Q3 2025).